Francesco DiMeco Selected Research

Francesco DiMeco Research Topics

Disease

26	Neoplasms (Cancer) 04/2022 - 11/2002
14	Glioblastoma (Glioblastoma Multiforme) 04/2022 - 10/2007
14	Glioma (Gliomas) 02/2020 - 11/2002
7	Brain Neoplasms (Brain Tumor) 03/2022 - 11/2002
4	Gliosarcoma 10/2006 - 11/2002
1	Carcinogenesis 05/2021
1	Spinal Cord Neoplasms (Spinal Cord Tumors) 01/2021
1	Nervous System Diseases (Neurological Disorders) 10/2019
1	Aneurysm (Aneurysms) 01/2019
1	Abscess 01/2019
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2019
1	Spinal Stenosis (Stenosis, Spinal) 06/2018
1	Fistula 04/2017
1	Central Nervous System Vascular Malformations (Dural Arteriovenous Fistula) 04/2017
1	Meningioma (Meningiomas) 05/2016
1	Optic Nerve Diseases (Optic Neuropathy) 05/2016
1	Residual Neoplasm 03/2016
1	Hydrocephalus (Hydrocephaly) 12/2013
1	Infratentorial Neoplasms (Posterior Fossa Tumors) 12/2013
1	Venous Thromboembolism 06/2013
1	Hemorrhage 06/2013
1	Neoplasm Metastasis (Metastasis) 09/2009
1	Brain Diseases (Brain Disorder) 09/2009

Drug/Important Bio-Agent (IBA)

5	PolymersIBA 02/2015 - 04/2003
4	Pharmaceutical PreparationsIBA 01/2021 - 11/2002
3	Biological ProductsIBA 05/2021 - 05/2003
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2010
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 02/2015
3	Contrast MediaIBA 10/2017 - 12/2015
3	Carmustine (FIVB)FDA Link 10/2006 - 04/2003
2	AntigensIBA 01/2021 - 01/2018
2	Temozolomide (Temodar)FDA LinkGeneric 05/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2012
2	LigandsIBA 09/2011 - 10/2007
2	decanedioic acid- 4,4'- (1,3- propanediylbis(oxy))bis(benzoic acid) copolymerIBA 05/2006 - 11/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2022
1	MitogensIBA 04/2022
1	Liposomes (Liposome)IBA 01/2021
1	alpha-hydroxyglutarateIBA 02/2020
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 02/2020
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2020
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 05/2019
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2019
1	AcidsIBA 01/2019
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2019
1	ChromatinIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	chondroitin sulfate proteoglycan 4IBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Chimeric Antigen ReceptorsIBA 01/2018
1	GadoliniumIBA 10/2017
1	MicroRNAs (MicroRNA)IBA 06/2015
1	Messenger RNA (mRNA)IBA 06/2015
1	RNA (Ribonucleic Acid)IBA 06/2015
1	Indicators and Reagents (Reagents)IBA 02/2015
1	ProdrugsIBA 02/2015
1	LipofectamineIBA 02/2015
1	Ganciclovir (Cytovene)FDA LinkGeneric 02/2015
1	Thymidine KinaseIBA 02/2015
1	Enoxaparin (Lovenox)FDA LinkGeneric 06/2013
1	AnticoagulantsIBA 06/2013
1	EphA2 ReceptorIBA 12/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2012
1	Notch ReceptorsIBA 09/2011
1	NestinIBA 09/2011
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 05/2010
1	Peanut AgglutininIBA 05/2010
1	Polysaccharides (Glycans)IBA 05/2010
1	LectinsIBA 05/2010
1	AgglutininsIBA 05/2010
1	Galactose (Galactopyranose)FDA LinkGeneric 05/2010
1	Chemokine ReceptorsIBA 09/2009
1	CXCR4 Receptors (CXCR4 Receptor)IBA 09/2009
1	Aldehyde DehydrogenaseIBA 10/2007
1	Coloring Agents (Dyes)IBA 10/2007
1	cyclopamineIBA 10/2007
1	Docetaxel (Taxotere)FDA Link 10/2006
1	Proteasome InhibitorsIBA 05/2006
1	lactacystinIBA 05/2006
1	EndostatinsIBA 11/2005

Therapy/Procedure

10	Therapeutics 04/2022 - 11/2002
4	Immunotherapy 05/2019 - 04/2003
3	Radiotherapy 01/2021 - 05/2012
3	Craniotomy 02/2019 - 12/2013
3	Drug Therapy (Chemotherapy) 05/2012 - 11/2002
2	Operative Surgical Procedures 03/2022 - 05/2014
2	Re-Irradiation 08/2015 - 06/2015
1	Precision Medicine 01/2022
1	Microbubbles 01/2021
1	Lasers (Laser) 01/2020
1	Piezosurgery 02/2019
1	Endoscopes 01/2019
1	Ventriculostomy 01/2019
1	Laminoplasty 06/2018
1	Laminectomy 06/2018
1	Chemoradiotherapy 01/2018
1	Intravenous Administration 10/2017
1	Ligation 04/2017
1	Intravenous Injections 12/2015
1	Perioperative Period 06/2013